Previous CDC data found that among people who aren ... withdrew the EUA for the monoclonal antibody tixagevimab-cilgavimab (Evusheld) in January 2023, people with moderate or severe immune ...

The FDA recently authorized a drug called Evusheld to help in this circumstance. Evusheld is a combination of two monoclonal antibodies. They work by binding to the spike protein and preventing it ...

Cost-effectiveness agency NICE has said it does not support NHS use of AstraZeneca’s antibody drug Evusheld for prevention of COVID-19, after rejecting it as a treatment for infected patients ...

The Department of Health said it would not be buying doses of the Evusheld injection. Charities and patient groups said they were disappointed by the decision. Blood Cancer UK said many ...

The Department of Health said it would not be buying doses of the Evusheld injection without more evidence about its effectiveness against Omicron. Scott Brigden, from Hedon, East Yorkshire ...